SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-026120
Filing Date
2018-04-25
Accepted
2018-04-25 17:25:36
Documents
1
Period of Report
2018-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2189
  Complete submission text file 0001209191-18-026120.txt   3554
Mailing Address C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Carter Eric G (Reporting) CIK: 0001387660 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36431 | Film No.: 18775255

Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Issuer) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations